Antimicrobial Therapy in Intensive Care Unit

This reprint is an excellent collection of articles that deal with difficult-to-treat infections in the ICU environment. Multiresistant bacteria and fungi create severe treatment problems to the physician charged with their care. We hope that this book will help everyday dilemmas and add useful info...

Полное описание

Сохранить в:
Библиографические подробности
Формат: Online
Язык:английский
Опубликовано: MDPI - Multidisciplinary Digital Publishing Institute 2023
Предметы:
HAP
VAP
ICU
n/a
Online-ссылка:ONIX_20230405_9783036567693_185
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!
_version_ 1869517121990426624
collection Directory of Open Access Books
description This reprint is an excellent collection of articles that deal with difficult-to-treat infections in the ICU environment. Multiresistant bacteria and fungi create severe treatment problems to the physician charged with their care. We hope that this book will help everyday dilemmas and add useful information on difficult topics.
format Online
id doab-20.500.12854ir-98906
institution Directory of Open Access Books
language eng
publishDate 2023
publishDateRange 2023
publishDateSort 2023
publisher MDPI - Multidisciplinary Digital Publishing Institute
publisherStr MDPI - Multidisciplinary Digital Publishing Institute
record_format ojs
spelling doab-20.500.12854ir-989062024-03-30T23:22:01Z Antimicrobial Therapy in Intensive Care Unit Paramythiotou, Elizabeth Routsi, Christina Andremont, Antoine Acinetobacter pandrug-resistant antimicrobial combinations synergy renal replacement therapy Monte Carlo simulation antibiotics pharmacokinetics pharmacodynamics microbiome probiotics intensive care unit dysbiosis ventilator-associated pneumonia extracorporeal membrane oxygenation ECMO critical illness antibiotic choices HAP VAP colonization antibiotic pressure bloodstream infection bacteraemia sepsis septic shock empirical probabilistic antibiotics source control de-escalation ICU intensive care antimicrobial stewardship COVID-19 procalcitonin C-reactive protein presepsin infection biomarker guided antimicrobial therapy APACHE II score bacteremia broth microdilution colistin colistin-resistant Gram-negative mortality SOFA score candidemia incidence epidemiology Candida species non-albicans Candida species fluconazole resistance critically ill beta-lactam antibiotics Acinetobacter baumannii antibiotic optimisation antibiotic stewardship (AMS) aspiration pneumonia hospital-acquired pneumonia (HAP) multidrug-resistance (MDR) non-fermentative Gram-negative bacilli (GNB) polymicrobial pneumonia resolution ventilator-associated pneumonia (VAP) carbapenem-resistant A. baumannii (CRAb) infection control antimicrobial agents carbapenems antibiotic resistance clinical pharmacy services Klebsiella pneumoniae Pseudomonas aeruginosa salvage treatment double carbapenem newer β-lactam-β-lactamase inhibitors cefiderocol eravacycline SARS-CoV-2 infection mechanical ventilation risk factors blood stream infection defined daily dose antibiotics utilization empiric n/a thema EDItEUR::M Medicine and Nursing This reprint is an excellent collection of articles that deal with difficult-to-treat infections in the ICU environment. Multiresistant bacteria and fungi create severe treatment problems to the physician charged with their care. We hope that this book will help everyday dilemmas and add useful information on difficult topics. 2023-04-05T12:58:29Z 2023-04-05T12:58:29Z 2023 book ONIX_20230405_9783036567693_185 9783036567693 9783036567686 https://directory.doabooks.org/handle/20.500.12854/98906 eng application/octet-stream Attribution 4.0 International https://mdpi.com/books/pdfview/book/6959 https://mdpi.com/books/pdfview/book/6959 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-0365-6768-6 10.3390/books978-3-0365-6768-6 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783036567693 9783036567686 260 Basel open access
spellingShingle Acinetobacter
pandrug-resistant
antimicrobial combinations
synergy
renal replacement therapy
Monte Carlo simulation
antibiotics
pharmacokinetics
pharmacodynamics
microbiome
probiotics
intensive care unit
dysbiosis
ventilator-associated pneumonia
extracorporeal membrane oxygenation
ECMO
critical illness
antibiotic choices
HAP
VAP
colonization
antibiotic pressure
bloodstream infection
bacteraemia
sepsis
septic shock
empirical
probabilistic antibiotics
source control
de-escalation
ICU
intensive care
antimicrobial stewardship
COVID-19
procalcitonin
C-reactive protein
presepsin
infection
biomarker
guided antimicrobial therapy
APACHE II score
bacteremia
broth microdilution
colistin
colistin-resistant
Gram-negative
mortality
SOFA score
candidemia
incidence
epidemiology
Candida species
non-albicans Candida species
fluconazole resistance
critically ill
beta-lactam antibiotics
Acinetobacter baumannii
antibiotic optimisation
antibiotic stewardship (AMS)
aspiration pneumonia
hospital-acquired pneumonia (HAP)
multidrug-resistance (MDR)
non-fermentative Gram-negative bacilli (GNB)
polymicrobial
pneumonia resolution
ventilator-associated pneumonia (VAP)
carbapenem-resistant A. baumannii (CRAb)
infection control
antimicrobial agents
carbapenems
antibiotic resistance
clinical pharmacy services
Klebsiella pneumoniae
Pseudomonas aeruginosa
salvage treatment
double carbapenem
newer β-lactam-β-lactamase inhibitors
cefiderocol
eravacycline
SARS-CoV-2 infection
mechanical ventilation
risk factors
blood stream infection
defined daily dose
antibiotics utilization
empiric
n/a
thema EDItEUR::M Medicine and Nursing
Antimicrobial Therapy in Intensive Care Unit
title Antimicrobial Therapy in Intensive Care Unit
title_full Antimicrobial Therapy in Intensive Care Unit
title_fullStr Antimicrobial Therapy in Intensive Care Unit
title_full_unstemmed Antimicrobial Therapy in Intensive Care Unit
title_short Antimicrobial Therapy in Intensive Care Unit
title_sort antimicrobial therapy in intensive care unit
topic Acinetobacter
pandrug-resistant
antimicrobial combinations
synergy
renal replacement therapy
Monte Carlo simulation
antibiotics
pharmacokinetics
pharmacodynamics
microbiome
probiotics
intensive care unit
dysbiosis
ventilator-associated pneumonia
extracorporeal membrane oxygenation
ECMO
critical illness
antibiotic choices
HAP
VAP
colonization
antibiotic pressure
bloodstream infection
bacteraemia
sepsis
septic shock
empirical
probabilistic antibiotics
source control
de-escalation
ICU
intensive care
antimicrobial stewardship
COVID-19
procalcitonin
C-reactive protein
presepsin
infection
biomarker
guided antimicrobial therapy
APACHE II score
bacteremia
broth microdilution
colistin
colistin-resistant
Gram-negative
mortality
SOFA score
candidemia
incidence
epidemiology
Candida species
non-albicans Candida species
fluconazole resistance
critically ill
beta-lactam antibiotics
Acinetobacter baumannii
antibiotic optimisation
antibiotic stewardship (AMS)
aspiration pneumonia
hospital-acquired pneumonia (HAP)
multidrug-resistance (MDR)
non-fermentative Gram-negative bacilli (GNB)
polymicrobial
pneumonia resolution
ventilator-associated pneumonia (VAP)
carbapenem-resistant A. baumannii (CRAb)
infection control
antimicrobial agents
carbapenems
antibiotic resistance
clinical pharmacy services
Klebsiella pneumoniae
Pseudomonas aeruginosa
salvage treatment
double carbapenem
newer β-lactam-β-lactamase inhibitors
cefiderocol
eravacycline
SARS-CoV-2 infection
mechanical ventilation
risk factors
blood stream infection
defined daily dose
antibiotics utilization
empiric
n/a
thema EDItEUR::M Medicine and Nursing
topic_facet Acinetobacter
pandrug-resistant
antimicrobial combinations
synergy
renal replacement therapy
Monte Carlo simulation
antibiotics
pharmacokinetics
pharmacodynamics
microbiome
probiotics
intensive care unit
dysbiosis
ventilator-associated pneumonia
extracorporeal membrane oxygenation
ECMO
critical illness
antibiotic choices
HAP
VAP
colonization
antibiotic pressure
bloodstream infection
bacteraemia
sepsis
septic shock
empirical
probabilistic antibiotics
source control
de-escalation
ICU
intensive care
antimicrobial stewardship
COVID-19
procalcitonin
C-reactive protein
presepsin
infection
biomarker
guided antimicrobial therapy
APACHE II score
bacteremia
broth microdilution
colistin
colistin-resistant
Gram-negative
mortality
SOFA score
candidemia
incidence
epidemiology
Candida species
non-albicans Candida species
fluconazole resistance
critically ill
beta-lactam antibiotics
Acinetobacter baumannii
antibiotic optimisation
antibiotic stewardship (AMS)
aspiration pneumonia
hospital-acquired pneumonia (HAP)
multidrug-resistance (MDR)
non-fermentative Gram-negative bacilli (GNB)
polymicrobial
pneumonia resolution
ventilator-associated pneumonia (VAP)
carbapenem-resistant A. baumannii (CRAb)
infection control
antimicrobial agents
carbapenems
antibiotic resistance
clinical pharmacy services
Klebsiella pneumoniae
Pseudomonas aeruginosa
salvage treatment
double carbapenem
newer β-lactam-β-lactamase inhibitors
cefiderocol
eravacycline
SARS-CoV-2 infection
mechanical ventilation
risk factors
blood stream infection
defined daily dose
antibiotics utilization
empiric
n/a
thema EDItEUR::M Medicine and Nursing
url ONIX_20230405_9783036567693_185